The medical device industry has unique challenges and opportunities. During 2020, many of these challenges, and opportunities, were highlighted even more so. It is a heavily regulated industry in most nations of the world. Devices need to be approved for reimbursement and prices are negotiated in many cases by group purchasing organizations and governments. Companies […]

This first edition report At-Home Testing: COVID-19 Trends and Future Potential provides an overview of trends and developments in the home testing industry for the pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).  This report covers trends that have occurred since the pandemic was declared in 2020 […]

By the middle of the decade, point of care testing is expected to reach 45 billion dollars annually.  This should not be surprising.  Globally, millions of dollars are spent annually on POC diagnostic testing, both professional testing and self-testing.  In 2020, sales of POC testing reached $29,316 million. COVID-19 was a significant game changer in […]

Contract manufacturing is an increasing part of the pharmaceutical business.  In cell therapy this need is magnified because of the demand for cell and gene therapy products.  Kalorama Information’s report the Market for Cell and Gene Therapy Contract Manufacturing Organizations (CMOs) details the following: Biopharmaceutical Contract Manufacturing Market Role Services Offered Usage Drivers Profiles of Companies, […]

Biomarkers are biological or biochemical molecules, genetic changes, or other characteristics that can be measured; they indicate or predict a condition, risk, or likely biological response. Biomarkers can be used for a range of diagnostic applications including diagnosis, predicting prognosis, identifying appropriate therapy for an individual, monitoring disease or for return of a disease, and […]

What is the Size of the IVD Market in 2021? What Impact has COVID-19 Had on IVD Markets? What Major Trends are Affecting the Market in 2021? Diagnostic test products have never been more important. This report, 2021 IVD Market Update and COVID-19 Impact, is an update of the market for in vitro diagnostics products […]

In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in Kalorama’s IVD Test Procedure Volumes, 2020-2025 saves time with calculations and estimates of both the existing number of procedures for scores […]

As the unfortunate milestone of one full year of the global COVID-19 pandemic worldwide is reached, the diagnostic industry has been changed, perhaps permanently.  Hundreds of test products are on the market to detect the virus, both for its presence and immune response.  And billions of dollars have been added to the in vitro diagnostic market.  […]

This report provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies such as Abbott and Roche and Quidel compete, but there are many other and new entrants since our last reporting. Molecular […]

Genetic involvement in the pathogenesis of neurological disease is significant. Central nervous system disorders account for approximately 60 percent of the 6,400 phenotypic entries in cataloged inherited human diseases.  Neurological diseases, especially brain diseases, are the last frontier in medical discovery. Advances in testing such as next-generation sequencing have been instrumental in identifying genetic causes […]